Previous Article | Next Article ![]()
Mol Cell Biol, March 1998, p. 1379-1387, Vol. 18, No. 3
Department of Molecular Pharmacology, Albert
Einstein College of Medicine, Bronx, New York 10461
Received 7 July 1997/Returned for modification 9 September
1997/Accepted 1 December 1997
We propose a novel model for the regulation of the p85/p110
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Regulation of the p85/p110 Phosphatidylinositol 3'-Kinase:
Stabilization and Inhibition of the p110
Catalytic Subunit by
the p85 Regulatory Subunit
phosphatidylinositol 3'-kinase. In insect cells, the p110
catalytic subunit is active as a monomer but its activity is decreased by coexpression with the p85 regulatory subunit. Similarly, the lipid kinase activity of recombinant glutathione S-transferase
(GST)-p110
is reduced by 65 to 85% upon in vitro reconstitution
with p85. Incubation of p110
/p85 dimers with phosphotyrosyl peptides
restored activity, but only to the level of monomeric p110
. These
data show that the binding of phosphoproteins to the SH2 domains of p85
activates the p85/p110
dimers by inducing a transition from an
inhibited to a disinhibited state. In contrast, monomeric p110 had
little activity in HEK 293T cells, and its activity was increased 15- to 20-fold by coexpression with p85. However, this apparent requirement
for p85 was eliminated by the addition of a bulky tag to the N terminus
of p110
or by the growth of the HEK 293T cells at 30°C. These
nonspecific interventions mimicked the effects of p85 on p110
,
suggesting that the regulatory subunit acts by stabilizing the overall
conformation of the catalytic subunit rather than by inducing a
specific activated conformation. This stabilization was directly
demonstrated in metabolically labeled HEK 293T cells, in which p85
increased the half-life of p110. Furthermore, p85 protected p110 from
thermal inactivation in vitro. Importantly, when we examined the effect
of p85 on GST-p110
in mammalian cells at 30°C, culture conditions
that stabilize the catalytic subunit and that are similar to the
conditions used for insect cells, we found that p85 inhibited p110
.
Thus, we have experimentally distinguished two effects of p85 on
p110
: conformational stabilization of the catalytic subunit and
inhibition of its lipid kinase activity. Our data reconcile the
apparent conflict between previous studies of insect versus mammalian
cells and show that p110
is both stabilized and inhibited by
dimerization with p85.
*
Corresponding author. Mailing address: Department of
Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-2153. Fax: (718) 430-8922. E-mail: Backer{at}AECOM.yu.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|